✦ LIBER ✦

Pre-therapeutic dosimetry and biodistribution of86Y-DOTA-Phe1-Tyr3-octreotide versus111In-pentetreotide in patients with advanced neuroendocrine tumours

✍ Scribed by Andreas Helisch; Gregor J. Förster; Helmut Reber; Hans-Georg Buchholz; Rudolf Arnold; Burkhard Göke; Matthias M. Weber; Bertram Wiedenmann; Stanislas Pauwels; Ulrike Haus; Hakim Bouterfa; Peter Bartenstein

Publisher: Springer
Year: 2004
Tongue: English
Weight: 357 KB
Volume: 31
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-004-1561-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of111In-DOTA-DPhe1-Tyr3-octre

Comparison of111In-DOTA-DPhe1-Tyr3-octreotide and111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours

✍ Margarida Rodrigues; Tatjana Traub-Weidinger; Shuren Li; Bettina Ibi; Irene Virg 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 255 KB

Concordance between results of somatosta

Concordance between results of somatostatin receptor scintigraphy with111In-DOTA-DPhe1-Tyr3-octreotide and chromogranin A assay in patients with neuroendocrine tumours

✍ Margarida Rodrigues; Michael Gabriel; Dirk Heute; Daniel Putzer; Andrea Griesmac 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 180 KB